Patent details

Basic Information

Publication number:

92785

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP078646932

Legal Status:

Inactive

Application number:

92785

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/15/999-C(2015)3218 -Zykadia-céritinib

Marketing Authorization Type:

Marketing Authorization Date:

08/05/2015

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Dates

Filing date:

29/07/2015

First Marketing Authorization date:

08/05/2015

Grant date:

03/11/2015

Activation date:

Publication date:

03/11/2015

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

08/05/2030

SPC Extension Expiration:

08/05/2030

Rejection date:

Withdrawal date:

Owner

From:

29/07/2015

 

 

Name:

NOVARTIS AG

Address:

LICHTSTRASSE 35, 4056, BASEL, Switzerland (CH)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

29/07/2015

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

PEI Wei

Address:

United States (US)

2

Name:

MICHELLYS Pierre-Yves

Address:

United States (US)

3

Name:

MARSILJE Thomas H.

Address:

United States (US)

4

Name:

CHEN Bei

Address:

United States (US)

5

Name:

UNO Tetsuo

Address:

United States (US)

Annual Fees

Annual Fee Due Date:

30/11/2027

Annual Fee Number:

21

Annual Fee Amount:

410 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages